Evidence map›Paper›PMID 38785412›Full record

ArticleRevista espanola de salud publica2024

[Brote de la COVID-19 en una residencia en ancianos correctamente vacunados. Influencia de la inmunidad híbrida en la carga viral, el riesgo de infección y el riesgo de progresión de la enfermedad].

Juan Carlos Gascó-Laborda, María Gil-Fortuño, Javier Ortiz-Rambla, Noemí Meseguer Ferrer, Óscar Pérez-Olaso, Lledó Lluch-Bacas, Raúl Moya-Malo, Diego Moliner Urdiales, Juan B Bellido-Blasco

Abstract readEnglish Abstract
In one paragraph

Article in Revista espanola de salud publica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Juan Carlos Gascó-LabordaSección de Epidemiología; Centro de Salud Pública de Castelló. Castellón. España.
María Gil-FortuñoServicio de Microbiología; Hospital Universitari de La Plana. Vila-real (Castellón). España.
Javier Ortiz-RamblaUnidad de Hospitalización Domiciliaria; Departamento de Salud de la Plana. Castellón. España.
Noemí Meseguer FerrerSección de Epidemiología; Centro de Salud Pública de Castelló. Castellón. España.
Óscar Pérez-OlasoServicio de Microbiología; Hospital Universitari de La Plana. Vila-real (Castellón). España.
Lledó Lluch-BacasSección de Epidemiología; Centro de Salud Pública de Castelló. Castellón. España.
Raúl Moya-MaloCentro de Salud Carinyena. Vila-real (Castellón). España.
Diego Moliner UrdialesUniversitat Jaume I. Castellón. España.
Juan B Bellido-BlascoSección de Epidemiología; Centro de Salud Pública de Castelló. Castellón. España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study addressed a COVID-19 outbreak in a nursing home, where the residents were vaccinated with two doses of Comirnaty® and thirty of them had previously had the infection. Outbreaks in closed communities are opportunities to study the entire clinical spectrum of the disease and, as in this case, the effect of hybrid immunity on transmission, infection progression and viral load.

methodsA descriptive and retrospective cohort study in the resident population was carried out. Attack rates were calculated for one of four stages of the disease: infection, symptomatic infection, hospitalization, and death. Relative risks (RR) were then estimated using simple and multivariate Poisson regression for each of these stages.

resultsThe attack rate was 59% (56/95). The clinical spectrum was the same in both sexes. There was a notable protective effect of hybrid immunity against transmission (67%). In terms of progression, those with hybrid immunity had a lower risk of symptomatic infection. Nasopharyngeal viral load was significantly lower in individuals with hybrid immunity and asymptomatic individuals, supporting the idea of lower transmissibility in this group. Age was identified as a risk factor for disease progression. Molecular analysis identified the Delta B.1.617.2 variant in the patients and an air sample, supporting aerosol transmission in closed, poorly ventilated environments.

conclusionsThis study provides a comprehensive view of an outbreak in a vaccinated nursing home, highlighting the importance of hybrid immunity. The results support the individual consideration of previous infection history when assessing the risk of COVID-19, contributing to the understanding of the evolution of the pandemic in the future.

Indexed as

COVID-19Nursing HomesAgedAged, 80 and overBNT162 VaccineCohort StudiesCOVID-19 VaccinesDisease OutbreaksFemaleHospitalizationHumansMaleMiddle AgedRetrospective StudiesSARS-CoV-2SpainBNT162 VaccineCOVID-19 VaccinesCOVID-19Hybrid immunityNursing homeOutbreakPandemicSpain

Identifiers

PMID38785412
PMCPMC11571694

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.